Ashland Global Holdings, Inc. ( (ASH) ) has released its Q4 earnings. Here is a breakdown of the information Ashland Global Holdings, Inc. presented to its investors.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Ashland Global Holdings, Inc. operates as a global additives and specialty ingredients company, primarily serving the pharmaceuticals, personal care, and architectural coatings markets with a focus on innovation and environmental responsibility.
In its fourth-quarter fiscal 2024 earnings report, Ashland announced a slight increase in sales and substantial growth in adjusted EBITDA, alongside significant portfolio optimization actions, including selling its nutraceuticals business and refining its product offerings.
Key financial highlights include sales of $522 million, a 1% increase from the previous year, and a 68% rise in adjusted EBITDA to $124 million. The company also reported an adjusted income from continuing operations of $61 million, or $1.26 per diluted share. Despite challenges such as softer coatings demand in China and production issues, Ashland repurchased 1.7 million shares and maintained strong cash flows.
Moving forward, Ashland plans to focus on high-value segments and manufacturing optimization, anticipating fiscal year 2025 sales between $1.90 billion and $2.05 billion, with adjusted EBITDA expected to range from $430 million to $470 million. Management aims to strengthen core operations and address competitive pressures, particularly in China, while continuing its strategic initiatives.
With a commitment to enhancing operational efficiency and pursuing growth in key markets, Ashland is poised to navigate the upcoming fiscal year, leveraging its technical expertise and market leadership to drive sustainable growth.
